Two common misconceptions about multiple sclerosis (MS) are that the disease of the central nervous system affects everyone the same way; and that being diagnosed with the condition guarantees ...
This week we are going to switch from orthopedics to neurologic conditions for a short time as this is something that is extremely prevalent in our geographic area. Multiple sclerosis is a disease of ...
Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...
Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...
The team, consisting of researchers from University College London (UCL) and Queen Square Analytics, analysed 634 patients ...
B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus)treats ...
Multiple sclerosis (MS) is thought to be an autoimmune inflammatory disease affecting the central nervous system and peripheral nerves. The cause remains unknown. It can be unpredictable and, in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results